1-15 of 15
Sort by
News

December Supplement 2023 Data Stream

Published: 2023
Abstract
December Supplement 2023
View News titled, December Supplement 2023 Data Stream
News

Pirtobrutinib Shows Durable Efficiency in Patients With Pretreated MCL Previously Treated With a Covalent BTK Inhibitor

Katie Robinson
Published: 2023
Abstract
December Supplement 2023
View News titled, Pirtobrutinib Shows Durable Efficiency in Patients With Pretreated MCL Previously Treated With a Covalent BTK Inhibitor
News

Scoring Tool Identifies Patients with MCL at High Risk of Developing Post-CAR-T Infections, Hematologic Toxicities

Anna Azvolinsky, PhD
Published: 2023
Abstract
December Supplement 2023
View News titled, Scoring Tool Identifies Patients with MCL at High Risk of Developing Post-CAR-T Infections, Hematologic Toxicities
News

CAR T-Cell Therapy Effective in Patients With Mantle Cell Lymphoma and Secondary Central Nervous System Disease

Katie Robinson
Published: 2023
Abstract
December Supplement 2023
View News titled, CAR T-Cell Therapy Effective in Patients With Mantle Cell Lymphoma and Secondary Central Nervous System Disease
News

Time to Progression Predicts Second-Line BTKi Outcomes After Firstline Rituximab in R/R MCL

Katie Robinson
Published: 2023
Abstract
December Supplement 2023
View News titled, Time to Progression Predicts Second-Line BTKi Outcomes After Firstline Rituximab in R/R MCL
News

Remission Sustained With Rituximab, Bendamustine, Cytarabine in Older Patients With Mantle Cell Lymphoma

Katie Robinson
Published: 2023
Abstract
December Supplement 2023
View News titled, Remission Sustained With Rituximab, Bendamustine, Cytarabine in Older Patients With Mantle Cell Lymphoma
News

Addition of Venetoclax to Lenalidomide Plus Rituximab Results in Durable Responses in Previously Untreated MCL

Anna Azvolinsky, PhD
Published: 2023
Abstract
December Supplement 2023
View News titled, Addition of Venetoclax to Lenalidomide Plus Rituximab Results in Durable Responses in Previously Untreated MCL
News

Preclinical Study Shows Potential of Dual Combination Therapy for Mantle Cell Lymphoma

Anna Azvolinsky, PhD
Published: 2023
Abstract
December Supplement 2023
View News titled, Preclinical Study Shows Potential of Dual Combination Therapy for Mantle Cell Lymphoma
News

Venetoclax Yields Good Overall Response Rate, Short Progression-Free Survival in High-Risk, Relapsed MCL

Katie Robinson
Published: 2023
Abstract
December Supplement 2023
View News titled, Venetoclax Yields Good Overall Response Rate, Short Progression-Free Survival in High-Risk, Relapsed MCL
News

Orelabrutinib Effective for the Treatment of R/R MCL

Lara C. Pullen, PhD
Published: 2023
Abstract
December Supplement 2023
View News titled, Orelabrutinib Effective for the Treatment of R/R MCL
News

Researchers Identify Single Nucleotide Polymorphisms That Shape Lenalidomide Responses in Mantle Cell Lymphoma

Thomas R. Collins
Published: 2023
Abstract
December Supplement 2023
View News titled, Researchers Identify Single Nucleotide Polymorphisms That Shape Lenalidomide Responses in Mantle Cell Lymphoma
News

Isoform of the Tyrosine Kinase AXL Identified in MCL

Anna Azvolinsky, PhD
Published: 2023
Abstract
December Supplement 2023
View News titled, Isoform of the Tyrosine Kinase AXL Identified in MCL
News

Targeting PRMT5 May Be Effective Therapy for MCL

Lara C. Pullen, PhD
Published: 2023
Abstract
December Supplement 2023
View News titled, Targeting PRMT5 May Be Effective Therapy for MCL
News

Patients With BTKi-Refractory Lymphoproliferative Disorders Respond to Pirtobrutinib

Katie Robinson
Published: 2023
Abstract
December Supplement 2023
View News titled, Patients With BTKi-Refractory Lymphoproliferative Disorders Respond to Pirtobrutinib
News

Hope on the Horizon

Leah Lawrence
Published: 2023
Abstract
December Supplement 2023 Hematologists are optimistic that bispecific antibodies could be a practical treatment for mantle cell lymphoma.
View News titled, Hope on the Horizon